Literature DB >> 7532244

Acteoside, a component of Stachys sieboldii MIQ, may be a promising antinephritic agent (2): Effect of acteoside on leukocyte accumulation in the glomeruli of nephritic rats.

K Hayashi1, T Nagamatsu, M Ito, T Hattori, Y Suzuki.   

Abstract

We investigated the effect of acteoside in comparison with that of cyclosporin A on leukocyte accumulation in the glomeruli of rats with crescentic-type anti-glomerular basement membrane (GBM) nephritis. Acteoside given p.o. at a dose of 30 mg/kg once a day for 15 consecutive days after treatment with anti-GBM serum markedly suppressed the urinary protein as well as glomerular histological changes. Acteoside given p.o. for 5 or 15 consecutive days markedly suppressed the accumulation of total leukocytes, ED-1-positive cells (monocytes/macrophages), CD4-positive cells, CD8-positive cells, interleukin-2-receptor-positive cells (activated T cells) and Ia-positive cells in the glomeruli. These effects of cyclosporin A (20 mg/kg/day, p.o.) were also as potent as those of acteoside (30 mg/kg/day, p.o.). Cyclosporin A also strongly suppressed the elevation of plasma antibody level against rabbit gamma-globulin. However, in this dose, acteoside did not significantly suppress the antibody formation. It can be concluded from these results that acetoside may exert its antinephritic action by suppressing the accumulation of leukocytes in the glomeruli.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7532244     DOI: 10.1254/jjp.66.47

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  6 in total

1.  In vivo treatment with the herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium-induced colitis.

Authors:  M Hausmann; F Obermeier; D H Paper; K Balan; N Dunger; K Menzel; W Falk; J Schoelmerich; H Herfarth; G Rogler
Journal:  Clin Exp Immunol       Date:  2007-05       Impact factor: 4.330

2.  Stachys schtschegleevii tea, matrix metalloproteinase, and disease severity in female rheumatoid arthritis patients: a randomized controlled clinical trial.

Authors:  Elham Mirtaheri; Alireza Khabbazi; Hossein Nazemiyeh; Ali-Asghar Ebrahimi; Mehrzad Hajalilou; Zahra Shakibay Novin; Saeed Pirouzpanah
Journal:  Clin Rheumatol       Date:  2021-11-11       Impact factor: 2.980

Review 3.  The pharmacokinetic property and pharmacological activity of acteoside: A review.

Authors:  Yaosheng Xiao; Qun Ren; Longhuo Wu
Journal:  Biomed Pharmacother       Date:  2022-06-17       Impact factor: 7.419

4.  Adenosine 3', 5' cyclic monophosphate attenuates the production of fibronectin in the glomeruli of anti-glomerular basement membrane antibody-associated nephritic rats.

Authors:  Tadashi Nagamatsu; Tsutomu Nishiyama; Isamu Goto; Toshiyuki Nagao; Yoshio Suzuki
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

5.  Acteoside improves survival in cecal ligation and puncture-induced septic mice via blocking of high mobility group box 1 release.

Authors:  Eun Sun Seo; Bo Kang Oh; Jhang Ho Pak; Soon-Ho Yim; Sangilyandi Gurunathan; Young-Pil Kim; Kyung Jin Lee
Journal:  Mol Cells       Date:  2013-04-04       Impact factor: 5.034

6.  Identification of novel natural compound inhibitors for human complement component 5a receptor by homology modeling and virtual screening.

Authors:  Faraz Shaikh; Shirley W I Siu
Journal:  Med Chem Res       Date:  2016-05-05       Impact factor: 1.965

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.